Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				FAQs: NIOSH-Interactive RadioEpidemiological Program (NIOSH-IREP)						Print
																Related Pages
										To determine probability of causation for a cancer claim under The Act, DOL uses a computer software application NIOSH has developed in collaboration with the National Cancer Institute, called NIOSH-IREP. This computer software is a science-based tool that allows DOL to determine the probability a cancer was caused by a person’s radiation dose from nuclear weapons production work. The actual outcome of a claim depends on a number of important factors such as the dose estimates of past exposures and the type of cancer that has been diagnosed. DCAS is responsible for maintaining and updating this software and the scientific elements (cancer risk models) that it uses.
To find answers to your questions about NIOSH-IREP, click any one of the questions listed below to view its answer.
NIOSH-Interactive RadioEpidemiological Program (NIOSH-IREP)What is IREP?
	The **I**nteractive **R**adio**E**pidemiological **P**rogram (IREP) is a web-based, interactive computer code that is used to estimate the probability that a given cancer in an individual was the result of a person’s occupational exposure to ionizing radiation.When was IREP developed?
	IREP was developed in 2002 by a Working Group of the National Cancer Institute (NCI) and Centers for Disease Control and Prevention (CDC).Why was IREP developed?
	IREP was developed to provide an update of the 1985 National Institutes of Health (NIH) Radioepidemiological Tables. The 1985 tables were developed from analyses of cancer mortality risk among the Japanese atomic bomb survivor cohort. These tables allow computation of the probability of causation for various cancers associated with a defined exposure to radiation, after accounting for factors such as age at exposure, age at diagnosis, and time since exposure.
A defining characteristic of IREP is that it accounts for uncertainties in estimating cancer risks due to exposure to ionizing radiation and in evaluating causation of a given cancer in an individual.What is NIOSH-IREP?
	The Energy Employees Occupational Illness Compensation Program Act of 2000 (EEOICPA or The Act) specified that the 1985 NIH Tables, as periodically updated, shall provide the basis for adjudication of claims for compensation for cancer under The Act. Accordingly, NIOSH adopted IREP for use by the U.S. Department of Labor (DOL) in adjudicating claims under The Act.
NIOSH-IREP is a customized version of IREP, created and maintained by NIOSH for use by DOL in adjudicating claims under The Act. NIOSH-IREP was originally developed to reflect the radiation exposure and disease experiences of employees covered under The Act.Has the NIOSH-IREP code ever been verified to ensure that it operates according to its intended use?
	Yes, a formal verification effort was undertaken and the report, Verification of the NIOSH-IREP Computer Code Version 5.5.3 Report (July 2009), presents the results of this effort. It was organized to ensure that the NIOSH-IREP software calculates risk and probability of causation (PC) according to the methodology agreed upon by NCI and NIOSH. This verification process was performed by individuals of SENES Oak Ridge, Inc., who were not involved in the initial development of the code. It is important to note that this effort has not attempted to “validate” or question the models and procedures developed by NCI and NIOSH; this effort “verifies” that each part of the NIOSH-IREP code operates according to its intended use described in its technical documentation.What is a cancer risk model?
	A cancer risk model is a mathematical relationship that expresses the risk of developing a specific cancer for a given dose of ionizing radiation and is used to estimate the probability of causation (PC).What are the cancer risk models based on?
	Risk models are based mainly on the observed cancer incidence from the Japanese atomic-bomb survivor study, but also from other epidemiological studies. The risk values in the models are adjusted for the U.S. population, based on U.S. cancer rates. Appropriate adjustments of the risk values are also made for low dose and low dose-rate exposure situations.Who maintains/updates NIOSH-IREP?
	NIOSH is responsible for maintaining and updating this software and the scientific elements (cancer risk models) that it uses.Is NIOSH-IREP claimant favorable?
	As applied, NIOSH-IREP is claimant favorable because it uses the upper 99-percent credibility limit to determine whether the cancers of employees are at least as likely as not caused by their occupational radiation doses.What cancer risk models are included in NIOSH-IREP?
	Cancer Risk Models Included in NIOSH-IREP
Acute Lymphocytic Leukemia
Acute Myeloid Leukemia
All digestive
All Male Genitalia
Bladder
Bone
Breast
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colon
Connective tissue
Esophagus
Eye
Female Genitalia, excl. ovary
Gallbladder
Leukemia, excl. CLL
Liver
Lung
Lymphoma & multiple myeloma
Malignant melanoma
Nervous system
Non-melanoma skin-Basal Cell
Non-melanoma skin-Squamous Cell
Oral cavity and pharynx
Other and ill-defined sites
Other endocrine glands
Other respiratory
Ovary
Pancreas
Rectum
Stomach
Thyroid
Urinary organs, excluding bladderWould NIOSH ever need to run more than one cancer risk model to determine the PC?
	Yes, some types of cancers require running more than one IREP model to see which one produces the highest probability of causation.How do I access the NIOSH-IREP software program?
	The NIOSH-IREP software program can be found at: https://irep.oraucoc.orgHow do I use the NIOSH-IREP software program?
	Log onto NIOSH-IREP
Choose either “manual entry” or “input file”
If using an input file, upload the file
Click “Browse” and navigate to selected file
Highlight selected file and click “Open”
Click “Upload file”
Click “Continue”
Click “Generate Results”
View results (print the Summary Report, if desired)Where can I find additional information on NIOSH-IREP?
	More information on NIOSH-IREP can be found on the NIOSH-IREP Software page.Who do I contact if I have additional questions about NIOSH-IREP?
	If you have more questions about NIOSH-IREP, please contact DCAS by email at dcas@cdc.gov or by phone at 513-533-6800.
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue